StockData
Cadre Holdings, Inc. logo

Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3023% above fair value
$30.56−1.32 (-4.14%)

Close on Nov 19, 2026Market cap $1.31BP/E 37.7Yield 1.24%

Cadre free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cadre's free cash flow for the twelve months ending Jun 30, 2026 was $78.12M, up 133.6% year over year. For fiscal 2025 it was $56.85M, up 117.7% from the year before. The highest annual figure on record is $66.48M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.85M+117.7%
FY2024Dec 31, 2024$26.11M-60.7%
FY2023Dec 31, 2023$66.48M+58.6%
FY2022Dec 31, 2022$41.92M+12.5%
FY2021Dec 31, 2021$37.26M-8.5%
FY2020Dec 31, 2020$40.71M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.68M+1504.6%
Q1 FY2026Mar 31, 2026$19.84M+23.4%
Q4 FY2025Dec 31, 2025$17.98M-19.8%
Q3 FY2025Sep 30, 2025$21.63M–
Q2 FY2025Jun 30, 2025$1.16M-87.2%
Q1 FY2025Mar 31, 2025$16.08M+1925.4%
Q4 FY2024Dec 31, 2024$22.42M-8.4%
Q3 FY2024Sep 30, 2024-$6.23M-138.6%
Q2 FY2024Jun 30, 2024$9.12M-34.5%
Q1 FY2024Mar 31, 2024$794.00K-93.4%
Q4 FY2023Dec 31, 2023$24.47M+59.4%
Q3 FY2023Sep 30, 2023$16.15M+301.9%
Q2 FY2023Jun 30, 2023$13.92M-4.5%
Q1 FY2023Mar 31, 2023$11.94M+49.9%
Q4 FY2022Dec 31, 2022$15.35M+80.7%
Q3 FY2022Sep 30, 2022$4.02M+157.1%
Q2 FY2022Jun 30, 2022$14.58M+30.7%
Q1 FY2022Mar 31, 2022$7.97M-50.3%
Q4 FY2021Dec 31, 2021$8.50M-48.3%
Q3 FY2021Sep 30, 2021$1.56M–
Q2 FY2021Jun 30, 2021$11.16M–
Q1 FY2021Mar 31, 2021$16.04M–
Q4 FY2020Dec 31, 2020$16.43M–

More Cadre figures

See a number that looks wrong?